Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 16/20 | 0.69 |
| ▸ | BRD4 | O60885 | 7/20 | 0.68 |
| ▸ | BRDT | Q58F21 | 5/20 | 0.68 |
| ▸ | PLK3 | Q9H4B4 | 6/20 | 0.61 |
| ▸ | RAD52 | P43351 | 1/20 | 0.61 |
| ▸ | PTK2 | Q05397 | 4/20 | 0.60 |
| ▸ | PLK2 | Q9NYY3 | 3/20 | 0.60 |
| ▸ | PDXK | O00764 | 2/20 | 0.60 |
| ▸ | NEK3 | P51956 | 2/20 | 0.60 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.60 |
| ▸ | WEE1 | P30291 | 1/20 | 0.60 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.59 |
| ▸ | CLK2 | P49760 | 3/20 | 0.59 |
| ▸ | CAMK2G | Q13555 | 3/20 | 0.59 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.59 |
| ▸ | PRKD2 | Q9BZL6 | 3/20 | 0.59 |
| ▸ | CSNK1G1 | Q9HCP0 | 3/20 | 0.59 |
| ▸ | CSNK1G3 | Q9Y6M4 | 3/20 | 0.59 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.59 |
| ▸ | PRKCG | P05129 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1203630 | 1.00 | PLK1 (0.69) | PLK1BRD4BRDTPLK3RAD52 | |
| SCHEMBL12879981 | 1.00 | PLK1 (0.69) | PLK1BRD4BRDTPLK3RAD52 | |
| SCHEMBL1202880 | 0.98 | PLK1 (0.66) | PLK1BRD4BRDTPLK3RAD52 | |
| SCHEMBL3547869 | 0.94 | PLK1 (0.74) | PLK1BRD4BRDTPLK3RAD52 | |
| SCHEMBL1203225 | 0.94 | PLK1 (0.68) | PLK1BRD4BRDTPLK3RAD52 | |
| SCHEMBL15498647 | 0.94 | PLK1 (0.68) | PLK1BRD4BRDTPLK3RAD52 | |
| Plogosertib SCHEMBL1202614 | 0.94 | PLK1 (0.75) | PLK1BRD4BRDTPLK3RAD52 | |
| SCHEMBL3541399 | 0.94 | PLK1 (0.74) | PLK1BRD4BRDTPLK3RAD52 | |
| Plogosertib SCHEMBL12879990 | 0.94 | PLK1 (0.75) | PLK1BRD4BRDTPLK3RAD52 | |
| Plogosertib SCHEMBL29919216 | 0.94 | PLK1 (0.75) | PLK1BRD4BRDTPLK3RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2205603-B1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CYCLACEL LTD (GB) | 2014-01-15 | — | — | EP | claimed |
| US-9493471-B2 | Pyrimidine derivatives as protein kinase inhibitors | CYCLACEL LIMITED (GB) | 2016-11-15 | — | — | US | disclosed |
| EP-2610256-B1 | Pyrimidine derivatives as protein kinase inhibitors | CYCLACEL LTD (GB) | 2016-04-27 | — | — | EP | disclosed |
| US-20150344486-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CYCLACEL LIMITED (GB) | 2015-12-03 | — | — | US | disclosed |
| US-20150344486-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CYCLACEL LIMITED (GB) | 2015-12-03 | — | — | US | disclosed |
| US-20150344486-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CYCLACEL LIMITED (GB) | 2015-12-03 | — | — | US | disclosed |
| US-20150320762-A1 | TREATMENT OF PROLIFERATIVE DISEASES WITH PYRIMIDODIAZEPINONES | CYCLACEL LIMITED (GB) | 2015-11-12 | — | — | US | disclosed |
| US-9133199-B2 | Pyrimidine derivatives as protein kinase inhibitors | CYCLACEL LIMITED (GB) | 2015-09-15 | — | — | US | disclosed |
| US-9133199-B2 | Pyrimidine derivatives as protein kinase inhibitors | CYCLACEL LIMITED (GB) | 2015-09-15 | — | — | US | disclosed |
| US-9133199-B2 | Pyrimidine derivatives as protein kinase inhibitors | CYCLACEL LIMITED (GB) | 2015-09-15 | — | — | US | disclosed |
| US-20140066436-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | TETHRA BIOSCIENCES INC. | 2014-03-06 | — | — | US | disclosed |
| US-20140066436-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | TETHRA BIOSCIENCES INC. | 2014-03-06 | — | — | US | disclosed |
| US-20140066436-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | TETHRA BIOSCIENCES INC. | 2014-03-06 | — | — | US | disclosed |
| EP-2205603-B1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CYCLACEL LTD (GB) | 2014-01-15 | — | — | EP | disclosed |
| US-8563542-B2 | Pyrimidine derivatives as protein kinase inhibitors | CYCLACEL LIMITED (GB) | 2013-10-22 | — | — | US | disclosed |
| WO-2013154774-A1 | BLOCK COPOLYMERS FOR STABLE MICELLES | INTEZYNE TECHNOLOGIES, INC. (US) | 2013-10-17 | — | — | WO | disclosed |
| EP-2610256-A1 | Pyrimidine derivatives as protein kinase inhibitors | Cyclacel Limited (GB) | 2013-07-03 | — | — | EP | disclosed |
| US-20110046093-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CYCLACEL LIMITED (GB) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046093-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CDK7, CDK9, CDK8 | PLK1 355/4885BRD4 589/4885BRDT 676/4885 |
| US-20140066436-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | CDK7, CDK9, CDK8 | PLK1 349/4885BRD4 669/4885BRDT 741/4885 |
| US-20150320762-A1 | TREATMENT OF PROLIFERATIVE DISEASES WITH PYRIMIDODIAZEPINONES | CDK7, NR3C2, CCNH | PLK1 2698/4885BRD4 531/4885BRDT 1196/4885 |
| US-20150344486-A1 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | DCK, DTYMK, TK1 | PLK1 23/4885BRD4 1149/4885BRDT 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.